Chargement en cours...
Phase I trial of M(2)ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer
Pancreatic cancer is one of the most lethal and resistant to treatment of solid tumors. Combination therapies with various types of drugs against pancreatic cancer have been extensively investigated. Endostatin is a potent endogenous inhibitor of angiogenesis, which may be administered in combinatio...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4051555/ https://ncbi.nlm.nih.gov/pubmed/24940500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.271 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|